Evaluating cancer therapies combining radiotherapy with immunotherapy or inhibitors of the DNA damage response
Establishment of spatial transcriptomics assay to find the mechanism of immune therapy against tumors
Development of an integrated in vitro and in vivo OVA-specific system for cancer vaccine discovery
Developing drug-induced resistant tumor models for efficacy evaluation of next-generation anticancer therapies
Intra-carotid artery brain metastasis models for the evaluation of lung and breast cancer drugs
Brain metastasis mouse models for the evaluation of multikinase inhibitors on ROS1-fusion-positive lung cancer
Comprehensive Comparison of Three-dimensional (3D) culture systems as Compound Screening Platforms in Primary Cancer Cell Lines
Drug Hunter: Discovering New Frontiers in Cancer Treatments & Beyond
Interview of Dr. Phil Jones, VP of Therapeutics Discovery
Specialty Chemistry Platform and Capabilities at WuXi AppTec RSD
Cutting-edge synthetic technology and expertise in special chemical matters
Merging a Passion for Biochemistry, Synthetic Chemistry, and Bioactive Molecules in Academia
Interview of Dr. Joseph Ready, Co-Founder, Rodeo
Empowering Chemistry with Quantum Mechanics
WuXi’s RSD teams are applying and developing QM calculations in multiple areas for organic syntheses
DELopen: DNA Encoded Library (DEL) Platform Offering more than 2.8 Billion Compounds
Apply for DNA-Encoded Library compound for free
Shifting the Paradigm of Resistance and Undruggables for Unmet Medical Needs in Cancer, Neuroscience, and Beyond
Interview of John Houston, Arvinas
DELopen Promotes Worldwide Academic Research Using DNA-Encoded Libraries, Far More Than Just a Numbers Game
Interview of Dr. Richard Lerner
OncoWuXi Database: To Facilitate Oncology Drug Discovery and Translational Oncology
Providing a portable oncology database for selection and inquiry of 1,000+ models for cancer research